Good post Kelt and great to see you on and sharing your thoughts. I really think you hit the nail on the head here. I can't help but think of Leo's opening at the Rodman and Renshaw conference where he said something along the lines of "at cellceutix we won't tell investors we love them while we drag our feet, instead we take action to keep the business moving forward".

He and Dr M i think at this point, knowing what they know, have an overall strategy in place to get where they need to be. 5 cents up or down is absolutely irrelevant, because as you said - they have the funds, the plan, and the strong human assets and partners in place to see this through as needed.

And its funny things are relatively quiet now, as i continue to believe that if we really can get 9 cohorts at DF and get breakthrough designation, CTIX as a whole will become simply irresistible to a big pharma at that point and things will get awful 'loud' very fast. After a breakthrough designation, it would be insane to continue to let kevetrin advance through stage 2/3 trials as it gets dramatically more expensive to own. But that's just me, the eternal optimist talking.